Latest Conference Articles

MauiDerm Connect will live stream in September

MauiDerm Connect will live stream in September

August 11th 2020

Maui Derm

Top educators in dermatology will come together to deliver CME lectures and engaging panel discussions via a premiere virtual platform. Learn more about MauiDerm Connect coming September 23-27.

Can botulinum toxin benefit rosacea patients?

Can botulinum toxin benefit rosacea patients?

July 23rd 2020

American Academy of Dermatology

Botulinum toxin may help address erythema and flushing in patients with refractory rosacea, according to data presented by Hema Sundaram, MA, MD, FAAD, at the AAD Virtual Meeting Experience (VMX) on June 12.

Bimekizumab phase 3 data reflect rapid, durable response

Bimekizumab phase 3 data reflect rapid, durable response

June 29th 2020

American Academy of Dermatology

Phase 3 data announced at the American Academy of Dermatology (AAD) Virtual Meeting Experience (VMX) 2020 demonstrate that the second-generation IL-17 inhibitor may offer long-lasting, safe treatment for patients with psoriasis.

Sebaceous gland destruction a viable strategy to treat acne

Sebaceous gland destruction a viable strategy to treat acne

April 22nd 2020

Maui Derm

Speaking about device-based acne treatments at Maui Derm for Dermatologists 2020 meeting, Fernanda Sakamoto, Ph.D., M.D., discussed PDT and other approaches for targeting the sebaceous gland.

Maui Derm sheds light on emerging COVID-19 data

Maui Derm sheds light on emerging COVID-19 data

April 21st 2020

Maui Derm

George Martin, M.D., dermatologist and program director for the Maui Derm meetings, has been working with the Maui Derm faculty, immunologists and members of industry to share emerging data regarding the novel coronavirus with the dermatology community. Listen to his insights in this video.

Experts advise caution over early, emerging treatments

Experts advise caution over early, emerging treatments

March 25th 2020

American Academy of Dermatology

Experts sent a letter to the White House Coronavirus Task Force March 24, outlining concerns about a growing shortage of medications required for managing patients with lupus and rheumatoid arthritis after President Donald Trump said in a March 19 press conference that the anti-malaria drug hydroxychloroquine could treat COVID-19.

AAD develops coronavirus resource center to support members through outbreak

AAD develops coronavirus resource center to support members through outbreak

March 20th 2020

American Academy of Dermatology

As the national pandemic continues to escalate, the American Academy of Dermatology is actively compiling resources related to the novel coronavirus to support its members and their practices. 

AAD issues guidance on biologic therapy during COVID-19 pandemic

AAD issues guidance on biologic therapy during COVID-19 pandemic

March 19th 2020

American Academy of Dermatology

The American Academy of Dermatology (AAD) has issued interim recommendations for practitioners to balance the risk of immunosuppression with the risk of disease flare amid COVID-19 pandemic.

Carnac the Magnificent of new drugs and treatments

Carnac the Magnificent of new drugs and treatments

January 29th 2020

Maui Derm

In a skit depicting Carnac the Magnificent, Drs. Rosen and Bhatia presented on 2020's new drugs and technologies at the current Maui Derm for Dermatologists, all with a magical twist.